Medico Remedies

What Medico Remedies does

Medico Remedies Limited is a publicly listed Indian pharmaceutical manufacturer founded in 1994, headquartered at Palghar, Maharashtra, with 51-100 employees and annual turnover in the stated range of ₹100-500 crores. The company operates a WHO-GMP and ISO 9001:2015 certified production facility and is described as a manufacturer and exporter of pharmaceutical formulations with specialization in Beta-Lactam antibiotics (penicillins and cephalosporins). Its product portfolio spans 17 therapeutic categories — including cardiovascular, anti-diabetic, antibiotics, antimalarial, NSAIDs, antidepressants, antiepileptics, oncology, erectile dysfunction, antifungals, and vitamins — delivered as tablets, capsules, oral suspensions, syrups, ointments, creams, and injectable formulations. The company's underlying technology is conventional pharmaceutical formulation manufacturing, with an in-house R&D team supporting product development rather than any disclosed proprietary platform or technology stack.

Medico Remedies generates revenue through B2B sales of pharmaceutical formulations, primarily to government medical supplies corporations and international export buyers. Distribution channels include direct supply to state health corporations (recently Uttar Pradesh Medical Supplies Corporation Limited via a ₹37.18 crore order), direct international exports (including a USD 1.12 million order from the Dominican Republic), domestic wholesale distribution, and IndiaMART marketplace listing. Pricing is quote-based per product with 'Get Best Quote' mechanics; unit prices range from approximately Rs 15 (Sildenafil) to Rs 530+ (Amoxicillin 1000mg) with minimum order quantities of 10,000+ boxes on selected items. The go-to-market motion is sales-led enterprise B2B, reliant on winning government tenders and bulk export contracts rather than recurring subscriptions.

Financially, the company recorded its highest-ever quarterly revenue of ₹58.68 crores in Q3 FY26, representing 48.59% year-over-year growth, with nine-month cumulative revenue of ₹149.57 crores approaching the prior full-year figure. However, profitability has compressed, with operating margin declining to 7.38% (from 7.88%) and PAT margin to 4.89% (from 6.63%) year-over-year. The stock has materially underperformed the broader market, declining 30.89% over the trailing year against an 8.79% Sensex gain. The company is founder-controlled under Director Harshit Mehta, with no disclosed private equity, venture capital, or institutional investor involvement.

Name

Medico Remedies

Legal name

Medico Remedies Limited

Website

https://medicoremediesindia.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

51–100 employees

Short description

Medico Remedies Limited is a WHO-GMP and ISO 9001:2015 certified Indian pharmaceutical manufacturer specializing in Beta-Lactam antibiotics and generic formulations, serving state government medical supplies corporations and international export buyers across 17 therapeutic categories.

Ownership category

akta.pro rank

Product category

Generic Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industry

Infectious Disease Specialty Pharmaceuticals (Non-vaccine) (HLAIACAM)

Keywords

• Generic pharmaceutical formulations
• Beta-lactam antibiotics manufacturing
• Cardiovascular drug formulations
• Pharmaceutical exporter India
• WHO-GMP certified manufacturing

Headquarters

HQ city

Thane

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Formulation Manufacturing & Export: Manufacturing and exporting pharmaceutical formulations including tablets, capsules, oral suspensions, syrups, ointments, and creams. Revenue generated through direct B2B sales to government health corporations and international export orders.
2. Government Supply Contracts: Securing large government supply orders from state medical supplies corporations for pharmaceutical drug distribution
3. International Export Orders: Fulfilling international export orders for pharmaceutical products to countries like Dominican Republic

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Medico Remedies manufactures and exports a wide portfolio of generic pharmaceutical formulations — including tablets, capsules, oral suspensions, syrups, ointments, creams, and injectable dosage forms — across 17 therapeutic categories such as cardiovascular, anti-diabetics, antibiotics, Beta-Lactam penicillins and cephalosporins, antimalarials, antifungals, anti-cancer, antidepressants/anti-epileptics, NSAIDs, ED medicines, vitamins, and anti-ulcer/antiparasitic drugs. Operations are anchored by a WHO-GMP and ISO 9001:2015 certified production facility in Palghar, Maharashtra, with an in-house R&D team and specialization in Beta-Lactam antibiotic formulations for government and international B2B buyers.

Product overview

Medico Remedies Limited is a WHO-GMP and ISO 9001:2015 certified pharmaceutical manufacturer based in Palghar, Maharashtra, India. The company specializes in Beta-Lactam antibiotics and cardiovascular medications, operating a large-scale production facility with an experienced R&D team. Their product portfolio spans 17 therapeutic categories including Cardiovascular (Lodipine, Irbesartan, Propranolol, Clopidogrel, Rosuvastatin), Antibiotics and Anti-Infectives (Lincomycin, Ciprofloxacin, Amoxicillin, Cefuroxime), Anti-Diabetics (Metformin, Glibenclamide, Gliclazide), Antipyretic Analgesics/NSAIDs (Paracetamol, Naproxen, Ibuprofen), Beta-Lactam/Penicillin and Cephalosporins, Antidepressants/Antipsychotics/Anti-epileptics (Carbamazepine, Amitriptyline), Antifungals (Clotrimazole, Ketoconazole), Topical Ointments and Creams (Diclomed Gel, Aciclovir Cream), Syrups and Dry Syrups, Vitamins and Supplements, Erectile Dysfunction medicines (Sildenafil), Antimalarials (Artemether+Lumefantrine, Primaquine), Anti-Cancer medicines (5 Fluorouracil), and Pharmaceutical Tablets and Gels. The company manufactures a wide range of formulations including tablets, capsules, oral suspensions, syrups, ointment creams, and injectables.

Differentiator

Problem solved

Functional benefit

Products and services

• Cardiovascular Pharmaceutical Formulations A cardiovascular drug product line of generic oral solid dosage formulations covering hypertension, dyslipidemia, and antiplatelet/anticoagulation therapy, intended for government medical supply agencies, hospitals, and export buyers requiring WHO-GMP certified cardiovascular generics.
• Anti-Diabetic Pharmaceutical Formulations Generic oral anti-diabetic tablets (biguanide and sulfonylurea classes) for Type 2 diabetes management, formulated for bulk supply to government health programs, pharmacies, and distributors in domestic and export markets.
• Antibiotics and Anti-Infectives Generic antibiotic and anti-infective oral formulations for treatment of bacterial and mixed bacterial-protozoal infections, intended for healthcare providers and government pharmaceutical procurement programs.
• Beta-Lactam Penicillin and Cephalosporin Formulations Specialized Beta-Lactam antibiotic formulations (penicillin and cephalosporin classes) manufactured in the company's dedicated, WHO-GMP certified Beta-Lactam facility, supplied to government healthcare tenders and international pharmaceutical buyers.
• Topical Ointments and Creams Topical dermatological cream formulations — antifungal and antiviral — for skin infections, formulated for bulk supply to pharmacies, hospitals, and government health distribution channels.
• Pharmaceutical Gels Topical analgesic gel formulations (NSAID-based) for joint and muscular pain management, intended for retail pharmacy and government pharmaceutical supply programs.
• Anti-Cancer Topical Formulations Topical oncology ointment formulations for dermatological pre-cancerous and superficial cancerous lesions, supplied to specialty oncology and dermatology channels.
• Erectile Dysfunction Medications Generic PDE5 inhibitor tablets for male erectile dysfunction treatment, supplied to pharmaceutical distributors, pharmacies, and export buyers.
• Antidepressants, Antipsychotics & Anti-Epileptics Generic CNS medications across antidepressant, anti-epileptic, and antipsychotic therapeutic classes, formulated for psychiatric and neurology pharmaceutical supply channels.
• Antipyretic, Analgesic & NSAID Formulations Generic over-the-counter and prescription analgesic, antipyretic, NSAID, and antihistamine tablet formulations for pain, fever, and allergy management, supplied for high-volume government and retail distribution.
• Antimalarial Medicines Generic antimalarial oral formulations (8-aminoquinolines and artemisinin-based combination therapy) for malaria treatment and relapse prevention, primarily serving government tropical-disease eradication programs and export markets.
• Antifungal Medicines Generic systemic and topical antifungal formulations for fungal and yeast infections, supplied to pharmacies, gynecological clinics, and government healthcare channels.
• Syrups and Dry Syrups (Oral Liquid Formulations) Liquid pharmaceutical formulations — vitamin supplements and reconstitutable oral antibiotic suspensions — for pediatric and adult patient populations, supplied to pharmacy and government distribution.
• Vitamins & Nutritional Supplements Generic vitamin and nutritional supplement products in syrup and tablet forms, distributed through pharmaceutical wholesale networks and export channels.
• Antacid, Anti-Ulcer Drugs & Antiparasitic Generic gastrointestinal and antiparasitic oral formulations — proton pump inhibitors and anthelmintics — for acid-related disorders and parasitic infections, supplied to retail pharmacy, government, and export distribution.

Quantifiable outcome

• Q3 FY26 quarterly revenue of ₹58.68 crores - highest in company history

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Two partnerships are on record, tiered core and minor.

• Uttar Pradesh Medical Supplies Corporation Limited (UPMSCL)coreChannel Partner/ Reseller/ Distributor · 27 January 2026Medico Remedies secured a government supply order worth ₹37.18 crore from UPMSCL for the supply of multiple pharmaceutical drugs, to be executed by October 31, 2026. This provides significant near-term revenue visibility for the company.
• Dominican RepublicminorOthers · 7 November 2025Medico Remedies secured a USD 1.12 million export order from Dominican Republic for pharmaceutical products, demonstrating international market expansion.

Scale indicators6 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Ajanta Pharma: India-based generic pharmaceutical manufacturer producing formulations across multiple therapeutic categories including antibiotics, cardiovascular, and anti-diabetics. Directly comparable as a mid-sized Indian generic pharma exporter with similar WHO-GMP operations and broad therapeutic portfolio.
• Medicamen Biotech: Small-to-mid sized Indian pharmaceutical manufacturer producing generic formulations including Beta-Lactam antibiotics, anti-infectives, and other therapeutic categories. Closely comparable in scale, manufacturing capabilities, and export focus.
• FDC Limited: Indian generic pharmaceutical manufacturer focused on formulations across anti-infectives, gastrointestinal, and other therapeutic areas. Comparable in scale, product breadth, and domestic plus emerging-market export orientation.
• Ipca Laboratories: Mid-sized Indian pharma manufacturer producing APIs and formulations spanning anti-malarials, antibiotics, cardiovascular, and pain management. Comparable as an Indian generic manufacturer with similar therapeutic breadth and export orientation.

Broad incumbents

• Glenmark Pharmaceuticals: India-based pharmaceutical company with operations in generics, specialty, and OTC across multiple therapeutic areas. Comparable therapeutic breadth and emerging-market focus, but with larger scale and more developed international infrastructure.
• Cipla: One of India's largest pharmaceutical manufacturers with strong presence in respiratory, anti-retroviral, and cardiovascular generics. Comparable in product categories and emerging-market export orientation, but with vastly greater scale and global brand recognition.
• Mankind Pharma: Major Indian pharmaceutical company with strong domestic presence across multiple therapeutic categories including antibiotics, cardiovascular, and anti-diabetics. Comparable product portfolio but with substantially larger scale and broader domestic distribution.
• Torrent Pharmaceuticals: Large Indian pharmaceutical manufacturer with strong portfolio in cardiovascular, central nervous system, and anti-infectives. Comparable therapeutic focus on cardiovascular and antibiotics but with significantly larger scale and broader international presence.
• Aurobindo Pharma: Major Indian generic pharmaceutical manufacturer with significant presence in antibiotics, including Beta-Lactam formulations. Comparable in Beta-Lactam specialization and broad therapeutic portfolio, but operates at substantially larger scale across global markets.
• Alkem Laboratories: One of India's top 10 pharmaceutical companies producing a wide range of generics including antibiotics, anti-infectives, and chronic disease medications. Comparable product portfolio but materially larger scale and broader geographic reach than Medico.

Market position

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xtwitter.com/share?url=https://www.medicoremediesindia.com/&text=Medico Remedies Limited
• Facebookfacebook.com/sharer.php?u=https://www.medicoremediesindia.com
• LinkedInlinkedin.com/company/medico-remedies-pvt-ltd-

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medico Remedies